NEJM Evid
Amyotrophic Lateral SclerosisNeurofilament ProteinsT-Lymphocytes, Regulatory
Dr. Simrit Parmar, MD
NPI1629047113
- Medicare services, 2023
- 375
- Part D claims, 2024
- 15
- Publications
- 147
- Clinical trials
- 2
- MIPS score, 2024
- 84
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Parmar's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Simrit Parmar is a hematologist and oncologist in Houston, Texas
Dr. Parmar practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Dr. Parmar's NPI, 1629047113, was assigned on March 16, 2006. Dr. Parmar graduated from Dayanand Medical College in 1998. Dr. Parmar holds Texas license M2002.
NPI and contact details
- NPI
- 1629047113NPI Registry (opens in a new tab)
- NPI enumeration date
- March 16, 2006
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 54
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Simrit Parmar practices at The University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Parmar's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.
- The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Houston, TX 77030
Source: Dmand AI Affiliation Data
Dr. Simrit Parmar is affiliated with 1 site of care
Dr. Parmar's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Simrit Parmar's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parmar practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Texas MD Anderson Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Parmar practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Simrit Parmar is one of 814 hematologists and oncologists in Texas
Hematology and oncology is Dr. Parmar's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Parmar's licenses on file in 13 states: Texas, Florida, California, New York, Arizona, Mississippi, Tennessee, Washington, Alabama, Georgia, Louisiana, Oklahoma and Illinois.
Specialties and state licenses
- Hematology and oncology, TexasPrimary
- Florida license
- California license
- New York license
- Arizona license
- Mississippi license
- Tennessee license
- Washington license
- Alabama license
- Georgia license
- Louisiana license
- Oklahoma license
- Illinois license
Clinical focus
Dmand AI lists cardiac arrhythmia, cellulitis, pneumonia and respiratory infection and sepsis among the conditions Dr. Parmar treats.
Hematologists and oncologists near Dr. Parmar
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
814hematologists and oncologists in Texas223hematologists and oncologists in Houston85hematologists and oncologists at The University of Texas MD Anderson Cancer Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Simrit Parmar billed Medicare for 375 services in 2023
CMS data shows 375 Medicare services from Dr. Parmar across 4 procedure codes in 2023. Medicare paid $36,675 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2023375
Paid by Medicare$36,675
Procedure codes4
Dr. Parmar's Medicare services by type, 2022 to 2023
- 2022
- 2023
- Office and hospital visits
- 2022: 2402023: 37556%
Dr. Parmar compared with the Texas median for hematologists and oncologists, 2023
- Dr. Parmar
- Texas median
- Medicare services
- 375vs 1,16268% below
- Part D claims
- 27vs 48994% below
Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.
Dr. Parmar's most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Parmar?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Parmar and other hematologists and oncologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Simrit Parmar's patients have a median age of 36
Across all payers, Dmand AI patient panel data puts Dr. Parmar's median patient age at 36, with 0% women.
Dr. Parmar's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 36
Patient panel by sex, all payers
- Women0%
- Men100%
Source: Dmand AI Patient Panel Data
Dr. Simrit Parmar wrote 15 Medicare Part D claims in 2024
In 2024, Dr. Parmar wrote 15 Medicare Part D claims. 100% of them were for generic drugs. They cover 2 drugs, with $411 in total drug cost. In 2019, CMS named 19 claims across 1 drug.
Part D claims, 202415
Drugs named by CMS2
Total drug cost$411
Dr. Parmar's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 192020: 2742%
Drugs named by CMS: 2 in 2020, 1 in 2019.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Simrit Parmar scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Parmar for performance year 2024, reported as part of a group.
Dr. Parmar's MIPS scores, performance year 2024
- 84of 100Final score
- 70.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 68of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Parmar by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Simrit Parmar has 147 publications on record
Dmand AI links 147 papers to Dr. Parmar, published from 2003 to 2025. 2016 was the busiest year, with 15. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Autologous and Graft vs Host Disease. Dr. Parmar has published most often in Biol Blood Marrow Transplant. Dr. Parmar's most frequent co-authors are Richard E. Champlin, MD, Elizabeth J. Shpall, MD and Chitra Hosing, MD.
Papers147
Years published2003 to 2025
Dr. Parmar's papers by year, 2016 to 2025
Topics Dr. Parmar writes about most
- Hematopoietic Stem Cell Transplantation
- Transplantation, Autologous
- Graft vs Host Disease
- Transplantation Conditioning
- Multiple Myeloma
- Antineoplastic Combined Chemotherapy Protocols
- Fetal Blood
- Leukemia, Myeloid, Acute
Dr. Parmar's most frequent co-authors
- Richard E. Champlin, MD80 shared papers
- Elizabeth J. Shpall, MD60 shared papers
- Chitra Hosing, MD57 shared papers
Recent publications by Dr. Parmar
AlbuminuriaCytokinesDisease Models, Animal
Anemia, AplasticBone Marrow DiseasesBone Marrow Failure Disorders
See who Dr. Parmar researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Parmar works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Simrit Parmar has worked on 2 clinical trials
Dmand AI links Dr. Parmar to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Sezary Syndrome and Mycosis Fungoides.
Conditions in Dr. Parmar's trials
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Sezary Syndrome
- Mycosis Fungoides
- Myeloproliferative Disorders
Recent clinical trials with Dr. Parmar
RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma (opens in a new tab)
TerminatedPhase 2
Sezary SyndromeMycosis FungoidesRFT5-dgA immunotoxin
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMyeloproliferative DisordersCyclophosphamideFludarabineMelphalan
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Simrit Parmar received $19,937 in industry payments from 2016 to 2023
CMS Open Payments shows 14 general payments to Dr. Parmar from 6 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 57% of the total. Genentech, Inc. paid the most, $16,374.
General payments to Dr. Parmar by program year, 2016 to 2023
General payments to Dr. Parmar by kind, 2016 to 2023
$19.9Kin total
- Travel and lodging$11,44657%
- Consulting fees$7,63438%
- Food and beverage$7834%
- Education$740%
Companies that paid Dr. Parmar the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Simrit Parmar graduated from Dayanand Medical College
Dr. Parmar graduated from Dayanand Medical College in 1998. Dr. Parmar is a member of ASCO.
- Medical school
Source: Dmand AI Professional Profile Data
Dr. Simrit Parmar accepts plans from 1 insurance carrier
Dr. Parmar is in network with 1 carrier, including Aetna. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Aetna
Plan types Dr. Parmar accepts, by number of carriers
- HMO1
- POS1
- PPO1
Source: Dmand AI Insurance Network Data
Sources for Dr. Simrit Parmar's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Simrit Parmar
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Simrit Parmar's NPI number?
Dr. Simrit Parmar's NPI number is 1629047113. It was assigned on March 16, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Simrit Parmar?
Dr. Simrit Parmar is a hematologist and oncologist in Houston, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Simrit Parmar practice?
Dr. Parmar practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Parmar's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
What is Dr. Simrit Parmar's medical license number?
Dr. Parmar holds Texas license M2002, one of the licenses on file in 13 states.
Which states has Dr. Simrit Parmar been licensed in?
Dmand AI has state licenses on file for Dr. Parmar in Texas (2005 to 2026), Florida (since 2021), California (2007 to 2026), New York (2024 to 2026), Arizona (2022 to 2025), Mississippi (2022 to 2025), Tennessee (2022 to 2025), Washington (2022 to 2025), Alabama (2022 to 2024), Georgia (2022 to 2024), Louisiana (2022 to 2024), Oklahoma (2020 to 2024) and Illinois (1998 to 2005).
Which hospitals is Dr. Simrit Parmar affiliated with?
Dr. Parmar practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.
Does Dr. Simrit Parmar accept Medicare?
Yes. CMS data shows Dr. Parmar billed Medicare for 375 services in 2023.
What is Dr. Simrit Parmar's MIPS score?
Dr. Parmar's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
What services does Dr. Simrit Parmar bill to Medicare?
In 2023, Dr. Parmar's most billed Medicare services were hospital inpatient care (99233), hospital inpatient care (99223) and hospital inpatient care (99239).
Where did Dr. Simrit Parmar go to medical school?
Dr. Parmar graduated from Dayanand Medical College in 1998.
Show 6 more questionsShow fewer questions
What drugs does Dr. Simrit Parmar prescribe most?
In 2020 Medicare Part D data, Dr. Parmar's most prescribed drugs by claims were Valacyclovir and Ondansetron HCl.
Has Dr. Simrit Parmar received payments from drug or device companies?
CMS Open Payments shows $19,937 in general payments to Dr. Parmar from 6 companies from 2016 to 2023. The largest total came from Genentech, Inc.
How long has Dr. Simrit Parmar been practicing?
Dr. Parmar graduated from medical school in 1998, 28 years ago.
Does Dr. Simrit Parmar do research?
Dmand AI links 147 publications to Dr. Parmar, published from 2003 to 2025. Dr. Parmar has worked on 2 clinical trials.
Who does Dr. Simrit Parmar publish with?
Dr. Parmar's most frequent co-authors are Richard E. Champlin, MD (80 shared papers), Elizabeth J. Shpall, MD (60 shared papers) and Chitra Hosing, MD (57 shared papers).
What insurance does Dr. Simrit Parmar accept?
Dr. Parmar is in network with 1 carrier, including Aetna. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card